Arenicin-1 vs Insulin Aspart
Head-to-head comparison of Arenicin-1 (Arenicin-1) and Insulin Aspart (Insulin aspart (B28-Asp human insulin analog)) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Arenicin-1 | Insulin Aspart |
|---|---|---|
| Category | Marine-Derived | Diabetes & Metabolic |
| Full Name | Arenicin-1 | Insulin aspart (B28-Asp human insulin analog) |
| Molecular Weight | 2079 Da | 5825.8 Da |
| Half-Life | n/a | About 1-3 hours |
| Amino Acids | 21 | 51 |
| Typical Dose | n/a | 0.05-0.2 U/kg per meal |
| Route | preclinical | Subcutaneous |
| Purity | ≥98% | ≥98% |
| Studies Count | 76 | 11000 |
| Research Status | Pre-clinical | Approved |
Arenicin-1 Benefits
- ✓antimicrobial
- ✓anti-biofilm
- ✓membrane-active
Insulin Aspart Benefits
- ✓Fast post-meal glucose lowering
- ✓Predictable onset
- ✓Flexible mealtime administration
- ✓Compatible with pump therapy
Arenicin-1 Dosing
bacterial infection|biofilm disruption
Insulin Aspart Dosing
Inject SC immediately before meals|Titrate using glucose monitoring and carbohydrate intake|Can be used in insulin pumps or basal-bolus regimens
Arenicin-1 Side Effects
- ⚠Arenicola marina
Insulin Aspart Side Effects
- ⚠Hypoglycemia
- ⚠Injection-site reactions
- ⚠Weight gain
Research Overview
Arenicin-1
Marine annelid peptide with strong preclinical antibacterial activity and a stable structural motif that is useful for peptide engineering.
Insulin Aspart
Research consistently shows faster onset and earlier peak action than regular human insulin. It is commonly studied for meal-time glycemic control and pump-based insulin delivery.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.